ToughBuilt Anticipates Positive Operating Cash Flow by Q3 2024

Stock Information for Oncternal Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Oncternal Therapeutics Inc.

ToughBuilt Industries, Inc. Announces Receipt of Nasdaq Staff Determination Letter and Hearing Request
ToughBuilt Industries Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
Toughbuilt Industries Announces Receipt of Nasdaq Delinquency Notice
ToughBuilt Obtains Purchase Order Financing to Fuel Supply Chain and Growth Initiatives
ToughBuilt Industries Announces Closing of $3.5 Million Public Offering
ToughBuilt Industries Announces Pricing of $3.5 Million Public Offering
ToughBuilt Industries Accelerates Growth with Expanded StackTech® Ecosystem, Targeting $6.8 Billion Market
ToughBuilt Industries, Inc. Announces Reverse Stock Split

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.